What You Should Know
The Peterson Health Technology Institute (PHTI) has released an independent health technology assessment evaluating virtual solutions for chronic kidney disease (CKD) management across stages 3–5.PHTI evaluated eight prominent commercial companies representing billions in private capital and market capitalization: DaVita Integrated Kidney Care (IKC), Evergreen Nephrology, Healthmap Solutions, Interwell Health, Kidneylink, Monogram Health, Somatus, and Strive Health.The
Read More
Digital Health | News, Analysis, Insights - HIT Consultant
Verily Secures Strategic Investment from NVIDIA to Accelerate Precision Health AI Platform
What You Should Know
Verily Health Inc. has secured a strategic equity investment from NVIDIA, extending its fundraising momentum following its corporate restructuring and initial $300 million funding round in early 2026.CU Healthcare Innovation Fund II, LP committed an additional follow-on investment, joining a capitalization syndicate that includes Alphabet (as a minority stakeholder), Series X Capital, and UCHealth.Directly accelerates commercial deployment of the Verily Pre Platform, the
Read More
H1 Acquires Healthcare Data Company Defacto Health to Bolster Provider Network Intelligence
What You Should Know
Healthcare professional intelligence leader H1 has acquired Defacto Health, a specialized healthcare data company focused on payer-provider networks, accepted insurance plans, and directory accuracy.The transaction formalizes a long-term data partnership, absorbing Defacto's proprietary directory auditing, error-cluster isolation, and network benchmarking engines directly into H1’s global platform.Defacto will operate directly within H1; co-founders Ron Urwongse and Tarun
Read More
Healthcare Doesn’t Need More AI Applications. It Needs Intelligent Orchestration.
Healthcare has entered a new phase of its AI journey.
The industry's early focus was understandable. Organizations wanted to identify practical use cases that could reduce administrative burden, improve productivity, and demonstrate measurable return on investment. AI-assisted documentation, coding assistance, prior authorization, and revenue cycle management have all generated meaningful momentum, proving that the technology can solve real operational challenges.
But as healthcare
Read More
Flatiron Health Renews NCCN Collaboration Through 2028 and Deploys Flatiron Telescope
What You Should Know
Flatiron Health, an independent affiliate of the Roche Group, has renewed its strategic oncology research partnership with the National Comprehensive Cancer Network® (NCCN®) through 2028, extending a collaborative alliance originally established in 2014.Core Academic Assets: Participating NCCN Member Institutions maintain access to Flatiron’s curated, de-identified real-world datasets spanning more than 6 million oncology patient journeys across academic and community
Read More
Forus Triples Raises $150M to Put AI Agents in Every Medical Practice
What You Should Know
Forus, the AI-powered network connecting physicians, retail and specialty pharmacies, commercial payers, and biopharma manufacturers, announced a $150M Series C financing round at a $3B valuation.The round triples the company’s valuation just months following its Series B round, lifting cumulative equity financing past $300M.Led by seed-stage backer Bain Capital Ventures, the insider round featured 100% reinvestment from existing institutional backers, including Thrive
Read More
Flow Neuroscience Launches FDA-Approved At-Home tDCS Treatment for Major Depressive Disorder
What You Should Know
Swedish neurotechnology company Flow Neuroscience officially launched FL-100 across the United States, introducing the first FDA-approved at-home transcranial direct current stimulation (tDCS) treatment for depression to the American market.Backed by formal premarket approval (FDA PMA P230024), the prescription-only medical device is indicated for adults (18+) with moderate to severe major depressive disorder (MDD) in the current episode who are not treatment-refractory,
Read More
GoodRx Launches Companion Family Plan Covering Children, Adults, and Pets with 250+ Free Medications
What You Should Know
Digital prescription and healthcare affordability leader GoodRx has launched the Companion Family Plan, expanding its direct-to-consumer everyday healthcare subscription to cover whole households, including domestic pets.Pricing is set at $24.99 per month on a month-to-month basis or $16.99 per month when billed annually, covering a primary subscriber and up to four dependents with no age limits.Members receive more than 250 eligible generic medications completely free
Read More
FDA Clears Kneu Health Apple Watch Tool for 24/7 Parkinson’s Tremor and Dyskinesia Monitoring
What You Should Know
The U.S. Food and Drug Administration (FDA) has cleared a new Apple Watch-based monitoring tool developed by Kneu Health for clinical tracking of Parkinson’s disease symptoms.Provides 24/7 continuous passive measurement of tremor alongside the platform's first-time capability to track dyskinesia—the involuntary movements often triggered as a side effect of long-term dopaminergic medications.Pairs continuous, passive smartwatch data with active, smartphone-based motor and
Read More
Ultrahuman Raises $70M to Build a Multimodal Human-Computer Interface for Health
What You Should Know
Bengaluru-based health intelligence company Ultrahuman announced a $70M financing round to evolve from a consumer wearable maker into an extensible human-computer interface (HCI) platform centered on the human body.The syndicate includes corporate heavyweights Qualcomm Ventures and Labcorp (via the Labcorp Venture Fund), alongside venture and growth investors Alpha Wave, Blume Ventures, Nexus Venture Partners, and Alteria Capital.Expands Pulsomics, an embedded opt-in
Read More
